Amgen Agrees To Buy Celgene’s Psoriasis Drug Archives

Nqaba Matshazi Nqaba has been working as an investigative journalist for the last 10 years. He has written for various media outlets across the world.

Pharma

Amgen Agrees To Buy Celgene’s Psoriasis Drug Otezla for $13.4 Billion

August 19, 2019 3616 Views

Amgen has agreed to buy Celgene Corporation’s psoriasis drug, Otezla for $13.4 billion in cash, a deal set ...